In Situ Hybridization Market Analysis: Major Players, Lucrative Segments And Top Geographies
27 Jul, 2023
The global in situ hybridization market size is expected to grow from $1.43 billion in 2022 to $1.57 billion in 2023 at a compound annual growth rate (CAGR) of 9.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global in situ hybridization market size is expected to reach $2.26 billion in 2027 at a CAGR of 9.6%.
Global In Situ Hybridization Market Key Driver
Increasing infectious diseases are predicted to drive the growth of the in-situ hybridization market in the future. Infectious diseases are conditions that spread from person to person by contaminated foods and beverages and pathogens such as viruses, bacteria, fungus, and parasites. In situ hybridization (ISH) tries to discover complementary nucleic acid sequences that are present in the tissue by using labeled nucleic acid sequences (probes) specific to the infectious organism, therefore an increasing infectious disease stimulates the growth of the in-situ hybridization industry.
Get a sample of the global in situ hybridization market reportGlobal In Situ Hybridization Market Segments
The global in situ hybridization market is segmented:
1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products
2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)
3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications
5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses
6) By Geography: The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global in situ hybridization market.
Major In Situ Hybridization Industry Players
Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc.
Get the full global in situ hybridization market reportIn Situ Hybridization Market Overview
In-situ hybridization refers to the method that enables the exact localization of a certain nucleic acid segment inside a histologic slice. In-situ hybridization is used for identifying sequences of nucleotides in tissues, including complete tissues, portions of tissues, and cells.
In Situ Hybridization Global Market Report 2023 provides data on the global in situ hybridization market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The in situ hybridization market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.